Faculty Disclosures
In accordance with Joint Accreditation criteria, the Association of Diabetes Care & Education Specialists (ADCES) must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest.
Joint Accreditation also requires that ADCES manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during an activity, please report it on the evaluation.
Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:
FacultyVivian Nnacho Ayuk, PharmD, CDCES - No conflicts of interest
Amy Hess Fischl, MS, RDN, LDN, BC-ADM, CDCES - Speakers Bureau: Abbott Diabetes Care, Xeris Pharmaceuticals
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP - Speakers Bureau: Novo Nordisk, Xeris Pharmaceuticals, Medtronic, Insulet, Dexcom, Abbott
LaurieAnn Scher, MS, RD, CDCES, FADCES - Stock Consultant : Tandem Mannkind, Mytonomy, Fitscript, ADCES (danatech)
Anthony Pick, MD, CDCES - Speakers Bureau: Abbott, BI/Lilly, AstraZeneca, Novo Nordisk
Daniel Ruck, DNP, FNP, RN, BC-ADM, CDCES - No conflicts of interest
Gary Scheiner MS, CDCES - Advisory Board: Provention Bio, Eli Lilly, Medtronic, Xeris Pharmaceuticals, Capillary Biomedical
PlannersJodi Lavin-Tompkins, MSN, RN, BC-ADM, CDCES – No conflicts of interest
Kellie Beumer, MBA – No conflicts of interest
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP – No conflicts of interest
LaurieAnn Scher, MS, RD, CDCES, FADCES – No conflicts of interest
The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.
Disclosure of Relevant Financial Relationships and Mechanism to Identify and Resolved Conflicts of Interest
Undertaking review of the educational activity to evaluate for potential bias, balance in presentation, evidence-based content or other indicators of integrity, and absence of bias.
Joint Providership
None
Financial Support
This activity is supported by an educational grant from Abbott.